'Pregnant women 12-17 years old' excluded from the 3rd quarter plan... When is the vaccination?

<Anchor>

There are people who are missing from the 3rd quarter vaccination plan announced by the government on the 17th. Teenagers under the age of 18 and pregnant women.

Medical reporter Yoo Seung-hyeon covered whether vaccination is possible, and if so, when it will be.

<Reporter>

Among the COVID-19 vaccines approved in Korea, the age of approval for AstraZeneca, Moderna, and Janssen vaccines is 18 years or older.

Pfizer Vaccine alone is age 16 or older.

The government's third quarter vaccination target is 18 years old or older, and 16-17 years old, who can get the Pfizer vaccine, are also excluded.

[17-year-old student: I think it would be good to get vaccinated during this year. It will be difficult to return to daily life, but I want to go to school in a somewhat free atmosphere.]

Last month, Pfizer applied to the Ministry of Food and Drug Safety to lower the vaccination age to 12.

Our government is still cautious.

The U.S. and European Medicines Agency last month extended the age of approval for Pfizer vaccines from 16 to 12 years of age.

Following the United States, Canada and Israel, Germany and France have also started immunizing adolescents.

Like these countries, it is possible that we will start immunization near the end of adult vaccination.

[Of gimjunseok / Pediatrics professional: getting a home propagation earned it appears that there could be a way to for herd immunity to vaccinated more than children, the safety of the youth to secure the vaccine 12 years -

in Korea Pregnant women are also not recommended to vaccinate for safety reasons.

In the United States and the United Kingdom, vaccination is classified as a high-risk group.

A study by the U.S. Department of Health found that the rates of miscarriages or premature births among the 35,000 vaccinated pregnant women were similar to those of unvaccinated pregnant women.

Health authorities will decide whether to vaccinate pregnant women and adolescents based on additional clinical trial data.

Even if an inoculation plan is set in the third quarter, it is likely that the inoculation will be possible after October considering the supply and demand.